University of Melbourne biomedical engineers have developed a 3D bioprinting system that rapidly fabricates structures mimicking human tissues. This new technology, called Dynamic Interface Printing (DIP), represents a significant advancement in tissue engineering and drug discovery.
Unlike traditional layer-by-layer bioprinters, DIP uses acoustic waves generated by vibrating bubbles to position cells within 3D printed structures. This approach allows for precise cell arrangement, crucial for creating accurate tissue models. David Collins, senior author of the study published in Nature, explains, "Just as a car requires its mechanical components to be arranged precisely for proper function, so too must the cells in our tissues be organized correctly."
The system's speed is a key advantage, printing cellular structures in seconds rather than hours. This rapid process enhances cell survival rates and maintains structure integrity. Additionally, DIP prints directly into standard laboratory plates, eliminating the need for delicate transfers and reducing the risk of contamination.
Search Antibodies Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.
Callum Vidler, the study's lead author, highlights the technology's potential impact: "We've developed our technology to address this gap, offering significant advancements in speed, precision, and consistency. This creates a crucial bridge between lab research and clinical applications."
The bioprinter's versatility allows for the creation of various tissue types, from soft brain tissue to harder materials like cartilage and bone. This capability opens new avenues for cancer research and drug development, potentially reducing reliance on animal testing.